rhIDU (recombinant human-Alpha-L-Iduronidase)
ALID-003-99
Phase 3 mab completed
Quick answer
rhIDU (recombinant human-Alpha-L-Iduronidase) for Mucopolysaccharidosis I is a Phase 3 program (mab) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Mucopolysaccharidosis I
- Phase
- Phase 3
- Modality
- mab
- Status
- completed